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Background. The increased practice of traditional Chinese medicine (TCM) worldwide has raised concerns regarding herb-drug
interactions. The purpose of our study is to analyze the concurrent use of Chinese herbal products (CHPs) among Taiwanese
insomnia patients taking hypnotic drugs. Methods. The usage, frequency of services, and CHP prescribed among 53,949 insomnia
sufferers were evaluated from a random sample of 1 million beneficiaries in the National Health Insurance Research Database. A
logistic regression method was used to identify the factors that were associated with the coprescription of a CHP and a hypnotic
drug. Cox proportional hazards regressions were performed to calculate the hazard ratios (HRs) of hip fracture between the two
groups. Results. More than 1 of every 3 hypnotic users also used a CHP concurrently. Jia-Wei-Xiao-Yao-San (Augmented Rambling
Powder) and Suan-Zao-Ren-Tang (Zizyphus Combination) were the 2 most commonly used CHPs that were coadministered with
hypnotic drugs. The HR of hip fracture for hypnotic-drug users who used a CHP concurrently was 0.57-fold (95% CI = 0.47–0.69)
that of hypnotic-drug users who did not use a CHP. Conclusion. Exploring potential CHP-drug interactions and integrating both
healthcare approaches might be beneficial for the overall health and quality of life of insomnia sufferers.
1. Introduction
Inadequate sleep and sleep disorders are common, and are
associated with an increased risk of poor health, diminished
work and academic performance, and negative safety out-
comes that have critical clinical and economic ramifications
[1]. Although substantial progress has recently been made
in the pharmacologic treatment of insomnia, including the
use of benzodiazepines and Z-drugs (zaleplon, zolpidem,
and zopiclone), adverse effects and the potential for abuse,
addiction, and the development of tolerance have led to
poor compliance for hypnotic regimens among insomniac
patients [2, 3]. Many poor sleepers have turned to traditional
Chinese medicine (TCM) remedies to manage their symp-
toms because they believe that such treatments exert fewer
subjective residual effects [4].
Although TCM remedies are promoted as natural, and
therefore harmless, complementary, and alternative medici-
nes that can also be used in Western countries [5, 6], data are
limitedregardingtheirsafetywhenusedincombinationwith
hypnotic drugs, particularly regarding the risk of herb-drug
interactions,suchasthatresultingfrominterferencewiththe
clearance of either of the drugs. Studies on the prevalence
of hypnotic-drug use and the prescription patterns of TCM
remedies among hypnotic-drug users are scant.
Comprising unique traditional therapies for various ail-
ments, TCM has been used in Taiwan for hundreds of years,
and its popularity remains unabated, despite the present
availability of modern medical care in Taiwan. In addition,
one distinguishing feature of the national healthcare system
in Taiwan is the coexistence of modern Western medicine
(WM) and TCM, including acupuncture and manipulative2 Evidence-Based Complementary and Alternative Medicine
therapies and Chinese herbal products (CHPs), claims for
which have been covered by the National Health Insurance
(NHI) system since 1995 [7].
P e o p l ei nT a i w a na r ef r e et oc h o o s ef r o mc a r eo ff e r e d
by WM clinics or TCM clinics. With an insured rate of
98% to 99%, the random sample that comprises the NHI
research database (NHIRD) is representative of the general
population of Taiwan and should allow a reasonably accurate
assessment of the concurrent usage of TCM and modern
medical resources in Taiwan; therefore, the NHIRD provides
an ideal platform for pharmacoepidemiological studies [8].
Our study aimed to describe the demographics and patterns
of CHP usage among hypnotic-drug users and, by using
a large population-based retrospective database, explore
the risk of hip fracture among a cohort of hypnotic-drug
users prescribed with a CHP concurrently compared with
hypnotic-drug users who did not use Chinese herbs. Our
findingsprovideevidence-basedinformationforformulating
appropriate management strategies for drug safety and inte-
grative medicine.
2. Materials and Methods
2.1. Data Source and Participants. Our study protocols were
approvedbytheInstitutionalReviewBoardoftheCommittee
onChineseMedicineandPharmacy(CCMP),Departmentof
Health, Taiwan. Our population-based study retrospectively
analyzed the reimbursement records of 1 million NHI ben-
eficiaries in the NHIRD that had been previously selected at
randomfromthe22millionbeneficiariesoftheNHItodeter-
mine the prevalence of concurrent CHP and hypnotic use
between January 1, 2002, and December 31, 2008, in Taiwan.
The electronic records of the NHIRD use beneficiary iden-
tification numbers that are encrypted and maintained by the
NationalHealthResearchInstitutes(NHRI)ofTaiwan[9,10].
The NHIRD records contain demographic information,
including age and sex, and clinical data, including all records
of clinical visits and hospitalizations, and all information
regarding prescribed drugs and dosages, including those
for CHPs. The diagnoses used in the NHIRD are coded
according to the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) [11].
Because the cost of all prescribed hypnotic drugs is
reimbursed by the NHI, they cannot be dispensed at a phar-
macy without a physician’s prescription. To construct a fixed
cohort, all outpatients with insomnia who used hypnotic
drugs, including benzodiazepines, zolpidem, and zopiclone,
were reviewed. For the purpose of studying the use of CHPs,
we downloaded the claims forms for reimbursed CHPs from
the website of the Bureau of National Health Insurance.
The corresponding information regarding the CHP was then
obtainedfromtheCCMPwebsite,includingthenameofeach
herb, the proportion of each constituent of the mixture, the
dateandperiodofapprovalforthedrug,theCCMPmanufac-
turercode,andthenameoftheCHPmanufacturer .AllCHP s
with the same CCMP standard formula are classified in the
same category, regardless of slight variations in the products
among different CHP manufacturers [12]. For our analysis of
the demographic and clinical variables, a coprescription of a
CHP and a hypnotic drug (defined as prescriptions for both
issued simultaneously or issued separately with overlapping
treatment periods) was used to determine the use of a CHP
a n dah y p n o t i cd r u go nt h es a m ed a y .
The participant selection from the NHIRD was per-
formed as shown in Figure 1. We reviewed all beneficiaries
with at least three outpatient visits with any nonorganic
insomnia (ICD-9-CM codes 307.40-42, 307.45-49, 780.50-52,
and 780.55-59) and excluded patients who were admitted
to hospital and received a hip fracture diagnosis between
1999 and 2001 (𝑛 = 138). Patients with hyperinsomnia
(ICD-9-CM codes 327, 307.43, 307.44, 780.53, and 780.54) for
t h ec a l e n d a ry e a ri nw h i c hi to c c u r r e dw e r ee x c l u d e d .Th e
prevalent insomnia cases diagnosed before the end of 2001
(𝑛=9 , 2 4 2 ) and patients under 20 years of age (𝑛 = 4,691)
were excluded to ensure that all participants had been newly
diagnosedwithadultinsomnia.Patientswithincompletedata
for age or sex (𝑛=2 1 ) and insomniac patients not taking
hypnotic drugs (𝑛 = 10,628) were also excluded.
2.2. Study Variables. To identify the key factors associated
with the coadministration of hypnotics and CHP among
insomnia sufferers (CAHCHP as an acronym for this pop-
ulation), we selected the demographic factors according to
previous studies [1, 7, 8]. Patients were classified, based
on age, into one of seven groups as follows: 20–29 years,
30–39 years, 40–49 years, 50–59 years, 60–69 years, 70–
79 years, and ≥80 years. The geographic areas of Taiwan
in which patients resided were classified as one of the
followingsevenregions:Taipeicity,Kaohsiungcity,Northern
region, Central region, Southern region, Eastern region, and
Outlying islands. Patients’ monthly income in New Taiwan
D o l l a r s( N T $ )w a sc a t e g o r i z e da so n eo ft h ef o l l o w i n gf o u r
levels: $0, $1–$19,999, $20,000–$39,999, and ≥$40,000.
The variables for hypnotic-drug use included in our
analyses were defined according to the specific proprietary
hypnotic preparation used during the study period. We cate-
gorizedthetypesofpreparationusedasfollows:long-half-life
benzodiazepine; short-half-life benzodiazepine; zolpidem;
zopiclone;andmixedregimens,includingtwo,three,ormore
of the aforementioned preparations.
T oe s t i m a t et h ei m p a c to fC H Pu s eo nt h er a t eo fh i p
fracture, we selected subjects who were first recorded with
a diagnosis of hip fracture (ICD-9-CM codes 820.0–820.9)
between January 1, 2002, and December 31, 2008. Further-
more, we also analyzed the risk of hip fracture according to
theperiodoftimepatientswereadministeredhypnoticdrugs
(≥30 days and <30 days).
2.3. Statistical Analysis. Data analysis was conducted using
descriptive statistics, including the prescription rates of
patients’ concurrent use of a CHP and a sedative hypnotic
drug stratified by age and sex, indications for the prescribed
CHP, and the most frequently coprescribed herbal formulas
for treating insomnia. The indications were coded according
to the ICD-9-CM and grouped into different broader disease
categories. The ICD-9-CM codes 460–519 were classified
as diseases of the respiratory system. Codes 780–799 were
grouped as symptoms, signs, and ill-defined conditions, andEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Flowchart of recruitment of subjects with insomnia from the 1 million random sample of the National Health Insurance Research
Database (NHIRD) from 2002 to 2008 in Taiwan.
codes 520–579 were classified as diseases of the digestive sys-
tem. Multiple logistic regression was conducted to evaluate
factors that correlated with CHP use based on the odds ratio
(OR)andthe95%confidenceinterval(CI).Coxproportional
hazards regressions were performed to calculate the hazard
ratio (HR) of hip fracture among hypnotic-drug users who
used a CHP concurrently and hypnotic-drug users who did
not use Chinese herbs. A significance level of 𝗼 = 0.05
was selected. The SAS statistical software, version 9.3 (SAS
Institute,Cary,NC,USA),wasusedfordatamanagementand
analyses.
3. Results
The database of outpatient claims contained information
for 64,670 sleep-disturbance sufferers during the 2002–2008
period. A total of 54,042 (83.6%) insomnia patients treated
with sedative-hypnotic drugs were included in our study.
Most of these patients used short-acting benzodiazepines.
Most of the sedative-hypnotic users (89.2%) also sought care
from TCM practitioners. Up to 37.0% (𝑛 = 19,994)o ft h e
sedative-hypnotic users received a coprescription for a CHP,
resultinginthecoadministrationofasedative-hypnoticdrug
with a CHP. Such patients who were coadministered the two
types of drug are hereafter referred to as CAHCHP patients.
A total of 19,994 CAHCHP patients were identified in our
insomnia cohort.
The hypnotic users who did not use a CHP were sig-
nificantly older and more likely to be male than were the
CAHCHP patients. More CAHCHP patients had income
levels of $20,000 to $39,999 and above, resided in Central
Taiwan, and used two or more types of sedative-hypnotic
drugs than the sedative-hypnotic users who did not use a
CHP. The adjusted ORs (aORs) and 95% CIs calculated using
t h el o g i s t i cr e g r e s s i o nm o d e la r ed i s p l a y e di nTable 1.A ft e r
adjusting for other factors, the aORs of CAHCHP patients
(aORs = 2.49) were higher for women than for men (aORs =
1.00) except patients aged 80 years and older. Compared with
the patients aged 40–49 years (aORs = 1.00), the aORs of the
CAHCHP patients decreased with age. Patients who used at4 Evidence-Based Complementary and Alternative Medicine
Table 1: Demographic characteristics and results of multiple logistic regression showing the adjusted odds ratio (aOR) and 95% confidence
interval (CI) of patients with newly diagnosed insomnia ever been prescribed hypnotic drugs from the 1 million random sample of the
National Health Insurance Research Database (NHIRD) from 2002 to 2008 in Taiwan.
Characteristics Total no.
Hypnotic users
without using
Chinese medicine,
no. (%)
Hypnotic users
coprescribed
Chinese medicine,
no. (%)
Hypnotic users coprescribed
Chinese medicine/hypnotic users
without using Chinese medicine
Odds ratio (95% CI)
Numbers of hypnotic users among insomnia
population
54,042 5,848 (10.8) 19,994 (37.0)
Sex
Male 19,354 3,234 (55.3) 6,350 (31.8) 1.00
(2.34–2.66)
Female 34,688 2,614 (44.7) 13,644 (68.2) 2.49
Mean (SD) age at inclusion, years 48.8 (15.4) 55.1 (17.2) 49.9 (14.9)
Age groups at inclusion, years no. (%)
20∼29 5,616 362 (6.2) 1,631 (8.2) 1.06 (0.93–1.22)
Male 184 (3.0) 477 (5.8)
Female 178 (3.2) 1,154 (2.4)
30∼39 11,105 891 (15.2) 3,820 (19.1) 1.03 (0.94–1.14)
Male 506 (6.6) 1,184 (13.2)
Female 385 (8.6) 2,636 (5.9)
40∼49 13,531 1,193 (20.4) 5,074 (25.4) 1.00
Male 675 (8.9) 1,536 (17.7)
Female 518 (11.5) 3,538 (7.7)
50∼59 10,637 1,072 (18.3) 4,184 (20.9) 0.85 (0.77–0.93)
Male 550 (8.9) 1,118 (15.3)
Female 522 (9.4) 3,066 (5.6)
60∼69 6,657 865 (14.8) 2,798 (14.0) 0.76 (0.68–0.84)
Male 488 (6.5) 962 (9.2)
Female 377 (8.3) 1,836 (4.8)
70∼79 4,787 922 (15.8) 1,951 (9.8) 0.52 (0.46–0.58)
Male 545 (6.5) 821 (5.7)
Female 377 (9.3) 1,130 (4.1)
Over 80 1,709 543 (9.3) 536 (2.7) 0.24 (0.21–0.28)
Male 286 (4.4) 252 (1.4)
Female 257 (4.9) 284 (1.3)
$NT/month (Premiums)
0 11,542 1,279 (21.9) 4,735 (23.7) 1.00
1–19,999 27,391 3,268 (55.9) 10,123 (50.6) 0.85 (0.79–0.92)
20,000–39,999 9,601 729 (12.5) 3,303 (16.5) 1.13 (1.01–1.26)
≥40,000 5,508 572 (9.8) 1,833 (9.2) 1.03 (0.91–1.17)
Insured area
Taipei city 9,495 1,159 (19.8) 3,239 (16.2) 1.00
Kaohsiung city 3,735 364 (6.2) 1,392 (7.0) 1.46 (1.27–1.68)
Northern Taiwan 14,900 1,848 (31.6) 4,929 (24.7) 0.98 (0.90–1.08)
Central Taiwan 12,554 824 (14.1) 5,490 (27.5) 2.49 (2.24–2.77)
Southern Taiwan 11,910 1,401 (24.0) 4,407 (22.0) 1.28 (1.16–1.41)
Eastern Taiwan 1,078 155 (2.7) 439 (2.2) 1.01 (0.82–1.24)
Outlying islands 370 97 (1.7) 98 (0.5) 0.36 (0.27–0.49)Evidence-Based Complementary and Alternative Medicine 5
Table 1: Continued.
Characteristics Total no.
Hypnotic users
without using
Chinese medicine,
no. (%)
Hypnotic users
coprescribed
Chinese medicine,
no. (%)
Hypnotic users coprescribed
Chinese medicine/hypnotic users
without using Chinese medicine
Odds ratio (95% CI)
Types and prescription patterns of hypnotics
Usual treatment regimens 16,182 1,352 (23.1) 3,310 (16.6) 1.00
Zolpidem 1,623 350 (6.0) 265 (1.3)
Zopiclone 109 16 (0.3) 20 (0.1)
BZD-long 8,657 293 (5.0) 1,703 (8.5)
BZD-short 5,793 693 (11.9) 1,322 (6.6)
Mixed regimens
Co-prescribed two types of hypnotics 18,466 2,168 (37.1) 6,734 (33.6) 1.30 (1.20–1.42)
Zolpidem + Zopiclone 79 20 (0.3) 18 (0.1)
Zolpidem + BZD-long 1,796 275 (4.7) 486 (2.4)
Zolpidem + BZD-short 4,418 849 (14.5) 1,499 (7.5)
Zopiclone + BZD-long 136 25 (0.4) 40 (0.2)
Zopiclone + BZD-short 308 63 (1.1) 99 (0.5)
BZD-long + BZD-short 11,729 936 (16.0) 4,592 (23.0)
Coprescribed more than two types of hypnotics 19,394 2,328 (39.8) 9,950 (49.8) 1.90 (1.75–2.06)
NT$ refers to new Taiwan dollars, of which 1US$ = 30NT$.
least two types of sedative hypnotic drugs (two types: OR =
1.30; 95% CI: 1.20–1.42 and ≥ t h r e et y p e s :O R=1 . 9 0 ;9 5 %C I :
1.75–2.06) were more likely to be CHP users than were the
patients who used only one sedative hypnotic drug.
By analyzing the percentage distribution of the 19,994
CAHCHP patients, we observed that sleep disturbance
(1,450,671TCM visits) was the most common major disease
category for coprescription events, followed by diseases of
the digestive system (1,349,092TCM visits) and the diseases
of the respiratory system (1,319,859TCM visits), as summa-
rized in Table 2.A ss h o w ni nTable 3, zolpidem, alprazolam,
lorazepam,estazolam,andfludiazepamwerethefivesedative
hypnotic drugs that were most frequently coprescribed with
aCHP.ThedetailsofthemostfrequentlyusedCHPformulas
are shown in Table 3. Suan-Zao-Ren-Tang (Zizyphus Combi-
n a t i o n )w a st h em o s tf r e q u e n t l yu s e dC H P ,f o l l o w e db yJia-
Wei-Xiao-Yao-San(AugmentedRamblingPowder)andTian-
Wang-Bu-Xin-Dan (Ginseng and Zizyphus Combination).
The average number of days of concurrent use of a sedative
hypnotic drug and a CHP was approximately 30 days per
CAHCHP patient during the 7-year study period.
The HRs of hip fracture for CAHCHP patients and
hypnotic-drug users who did not use Chinese herbs are pre-
sented in Table 4. After adjusting for potential confounders,
t h eH Ro fh i pf r a c t u r ef o rC A H C H Pp a t i e n tw a s0 . 5 7 - f o l d
(95%CI=0.47 –0.69)tha tofcomparisonsubjects.W efurther
analyzed the risk of hip fracture according to the length
of hypnotic treatment. Table 4 shows that, compared with
hypnotic-drug users who did not use Chinese herbs, the HR
of hip fracture for CAHCHP patients who were prescribed
hypnotics for ≥30 days was 0.62 (95% CI = 0.50–0.77) and as
low as 0.33 (95% CI = 0.20–0.54) for CAHCHP patient who
were prescribed hypnotics for <30days.Theincidencerateof
hipfractureamongtheCAHCHPpatientswasnohigherthan
that of hypnotic-drug users who did not use Chinese herbs
(≥30-day group: 3.4 versus 6.5 per 100 person-years; <30-day
group: 2.9 versus 11.1 per 100 person-years).
4. Discussion
According to our review of the literature, this study is the
first to use a random population-based cohort to document
t h ec o p r e s c r i p t i o no fh y p n o t i cd r u g sa n dC H P si ni n s o m -
nia patients in Taiwan. We observed that hypnotic use is
common among insomnia patients in Taiwan and that ben-
zodiazepines were the most frequently prescribed category
of sedative hypnotic, as shown in Table 1. Previous studies
havereportedthatpatientstreatedwithbenzodiazepinesmay
b ea th i g h e rr i s kf o rf a l l sa n dh a v eb e e na s s o c i a t e dw i t ha n
increased risk of hip fracture. Both physicians and patients
should be aware of the association between hypnotic use
and the potential risk for injury in Taiwan. The possibility
of recall or selection bias can be excluded because we
included patients who were newly diagnosed with insomnia
by qualified conventional physicians during the 2002–2008
period from a random sample of the population-based NHI
database.
The prevalence of the concurrent use of sedative hyp-
notics and CHPs was 37% (Figure 1). The abuse of benzo-
diazepines has become a serious problem in North America
[13]. The fear of sedative hypnotic side effects or dependency
may motivate patients to seek TCM therapies [2, 3, 14].
Although barbiturates have been reported to be the most
prescribedhypnoticinTaiwan,ourfindingsindicateachange6 Evidence-Based Complementary and Alternative Medicine
Table 2: Frequency distribution of traditional Chinese medicine (TCM) visits by major disease categories (according to 9th ICD codes) in
subjects with insomnia ever been prescribed hypnotic drugs from 2002 to 2008 in Taiwan.
Diagnosis ICD-9-CM codes
Treatment days (people)
Chinese herbal remedies Acupuncture and manipulative
therapies
Infectious and parasitic diseases 001–139 46,426 (2,027) 47 (14)
Neoplasms 140–239 63,080 (904) 777 (32)
Endocrine, nutritional, and metabolic
diseases and immunity disorders
240–279 213,461 (4,425) 890 (90)
Psychotic diseases 290–319 164,603 (4,417) 1,781 (135)
Somnambulism 307.4 57,639 (2,073) 268 (34)
Others 106,964 (2,542) 1,513 (105)
Disease of nervous system and sense organs 320–389 332,372 (10,391) 6,057 (1,200)
Disease of circulation system 390–459 257,825 (6,088) 4,384 (288)
Disease of respiratory system 460–519 1,319,859 (26,741) 2,334 (253)
Disease of digestive system 520–579 1,349,092 (25,113) 3,501 (275)
Disease of genitourinary system 580–629 824,093 (15,653) 4,102 (189)
Disease of the skin and subcutaneous tissues 680–709 238,578 (8,315) 857 (72)
Disease of musculoskeletal system and
connective tissue
710–739 647,207 (17,991) 135,465 (23,473)
Symptom, signs, and ill-defined conditions 780–799 3,036,297 (40,342) 11,642 (1,348)
Sleep disturbance 780.5 1,450,671 (35,386) 6,733 (590)
Others 1,585,626 (29,955) 4,909 (845)
Injury and poisoning 800–999 46,331 (3,324) 138,053 (26,466)
Supplementary classification V01–V82, E800–E999 375 (30)
0( 0 )
2( 2 )
4 (1)
Others
∗ 67,793 (2,570) 1,053 (353)
Total 8,607,392 (45,847) 310,943 (34,454)
∗Include ranges of 280–289, 630–677, 740–759, and 760–779 ICD-9-CM code and missing data.
T a b l e3 :Th et o pfi v ec o p r e s c r i b e dC h i n e s ef o r m u l a sa n ds e d a t i v ea n dh y p n o t i cd r u g sf o rt r e a t i n gi n s o m n i a( I C D 9 :3 0 7 . 4o r7 8 0 . 5 )b e t w e e n
2002 and 2008.
Chinese Medicine-sedative and hypnotic drugs Total days of
coprescribing
Total people of
coprescribing
Average days of
coprescribing Chinese
and Western medicine
(days/people)
Total
Formulae 1,507,601 18,837
Jia-Wei-Xiao-Yao-San (Augmented Rambling Powder) 70,708 4,029 17.5
Suan-Zao-Ren-Tang (Zizyphus Combination) 58,115 3,646 15.9
Tian-Wang-Bu-Xin-Dan (Ginseng and Zizyphus Combination) 46,040 2,744 16.8
Chai-Hu-Jia-Long-Gu-Mu-Li-Tang (Bupleurum and Mu Li Combination) 39,494 2,409 16.4
Gan-Mai-Da-Zao-Tang (Licorice and Jujube Combination) 38,158 2,097 18.2
Sedative and hypnotic drugs 2,041,718 19,994
Zolpidem
1 462,395 6,415 30.6
Alprazolam
1 313,833 4,990 27.0
Lorazepam
1 276,865 5,053 24.4
Estazolam
1 180,646 2,400 31.3
Fludiazepam
1 171,842 2,229 34.0
1Short-acting BZD (elimination half time ≤ 24 hours).Evidence-Based Complementary and Alternative Medicine 7
Table 4: Number (no.) of new cases, population-at-risk, and incidence rates and hazard ratios (HR); 95% confidence intervals (CI) for hip
fracture estimated from multivariate Cox regression model on a random sample of the National Health Insurance Research Database among
sample subjects and followed from 2002 to 2008.
Presence of hip fracture during the follow-up
period
Hypnotic users without
using Chinese medicine,
no. cases/population
Hypnotic users
coprescribed Chinese
medicine, no.
cases/population
Hypnotic users coprescribed
Chinese medicine/hypnotic users
without using Chinese medicine
HR (95% CI)
Numbers of hip fracturesamong hypnotic users 152/5,848 294/19,994 0.57 (0.47–0.69)
≥30 days
Incidence rate per 1,000 person-years
123/5,045
6.5
260/17,149
3.4 0.62 (0.50–0.77)
<30 days
Incidence rate per 1,000 person-years
29/803
11.1
34/2,845
2.9 0.33 (0.20–0.54)
in the prescribing habits of physicians, with nonbarbiturates,
particularly zolpidem, being coprescribed more frequently
than barbiturates. We also observed that poor sleepers who
were prescribed multiple types of hypnotics were more likely
to use a CHP concurrently compared with patients who did
not seek TCM treatment.
In Taiwan, the prescribing of hypnotic drugs must be
accompaniedbyastandardICD-9-CMdiagnosiscode[9,10]
toadheretotherequirementsforNHIclaimsreimbursement.
The change in prescription patterns that we observed might
represent an attempt by physicians to achieve a greater ther-
a p e u t i ce ff e c tf o rp a t i e n t sw i t hah i s t o r yo ft o l e r a n c e ,p o o r
response, or dependence in previous hypnotic-drug treat-
ment [15] or it might reflect an increasing concern among
physicians regarding the potential abuse of sedative hypnotic
drugs. Considering the increasing incidence of hypnotic-
CHP coprescriptions, we suggest that a more critical attitude
toward the use of hypnotics and CHPs in combination is
required among both physicians and hypnotic-drug users.
We observed that hypnotic-drug users who use a CHP con-
currentlywerenotmorestronglyassociatedwithanincreased
risk of hip fracture than were hypnotic users who did not
use Chinese herbs. Little is known regarding the potential
interactions of CHPs with hypnotic drugs; therefore, health-
care providersandpublic-healthpolicyanalystsshouldfocus
greater attention on the potential long-term impact of this
particular healthcare-seeking behavior on health outcomes
[16].
Our previous clinical trials demonstrated that Jia-Wei-
Xiao-Yao-San (Augmented Rambling Powder) and Suan-
Zao-Ren-Tang (Zizyphus Combination), the two CHPs that
were most commonly coprescribed with a hypnotic drug,
may be an efficacious therapy for improving sleep quality
[5, 6], as shown in Table 3. Among the five most frequently
coprescribed formulas for treating insomnia, Tian-Wang-Bu-
Xin-Dan (Ginseng and Zizyphus Combination), Gan-Mai-
Da-Zao-Tang (Licorice and Jujube Combination), and Chai-
Hu-Jia-Long-Gu-Mu-Li-Tang (Bupleurumand Mu Li Com-
bination) all have a long history of use in Taiwan. They
are said to nourish the blood and calm the nerves and are
frequently prescribed by TCM practitioners to alleviate sleep
disturbances [17].
TheconcomitantuseofbenzodiazepinesandZ-drugswas
the most common combination of hypnotics that were used
by patients who used multiple types of hypnotics. Because
of a lack of sufficient evidence supporting this less judicious
prescription pattern, we suggest that such patients may be
more likely to “doctor shop,” resulting in the high prevalence
of the concurrent use of CHPs and hypnotic drugs. Our
fi n d i n g si n d i c a t et h a tt h el o w e ri n c i d e n c er a t ea n dH Ro f
hipfractureinCAHCHPpatientsthanthatinhypnotic-drug
users who did not use Chinese herbs might imply that TCM
physicians in Taiwan encouraged insomnia patients to coad-
minister CHPs and hypnotic drugs to improve sleep quality,
which might allow lower hypnotic dosages and reduce the
risk of hypnotic adverse effects and dependence. However,
insufficient evidence exists to support such a conclusion.
Although previous studies have demonstrated that acu-
p u n c t u r em i g h tb ea na l t e r n a t i v et h e r a p yf o ri n s o m n i a[ 18,
19],ourdataindicatedthatinsomniapatientstypicallysought
acupuncture treatment for injury, poisoning, and diseases of
the musculoskeletal system and connective tissue. Following
insomnia, diseases of the digestive system were the second
most frequent disease category for TCM visits by CAHCHP
patients. These results indicate that health care providers
should also address the general health condition of insomnia
patients, particularly gastroenterological symptoms, to iden-
tify possible causes of insomnia and provide appropriate
treatment for other such medical needs that do not require
hypnotic treatment. Further studies are warranted to in-
vestigate the cost effectiveness of the coadministration of
h y p n o t i cd r u g sw i t hC H P sa n dc o m p r e h e n s i v eg a s t r o e n t e r -
ological care for insomnia patients, particularly those with a
history of hypnotic dependence.
Our study has three limitations: first, the NHI only
reimburses the cost of the CHP; the cost of decoction is
not reimbursed, which may have affected patients’ decisions
to use CHPs. Thus, the frequency of the concurrent use of
hypnotic drugs and CHPs may be underestimated in our
results. However, because the NHI provides comprehensive
coverage and the copayment for prescriptions is always $50
(approximately equal to US $1.50), which is less than the
t y p i c a lc o s to fh e r b ss o l di nT a i w a n ’ sm a r k e t s ,t h el i k e l i h o o d
that patients purchased herbs outside of the NHI system is
low. Second, we were unable to draw any conclusions regard-
ing the relationship between the severity of the insomnia
and TCM usage because such clinical data are not included
in the NHIRD. Third, the retrospective design of our study8 Evidence-Based Complementary and Alternative Medicine
and the lack of a randomized placebo group might diminish
the statistical power of our findings. Thus, our results must
be interpreted cautiously because we cannot exclude the
possibility of placebo effects.
5. Conclusion
Our findings may have implications for the treatment of
insomnia patients. Our results suggest that, with equal
availability of conventional medical and TCM care, more
thanone-thirdofthehypnotic-drugusersusedCHPsconcur-
rently for the relief of sleep disturbance and gastroenterolog-
ical symptoms. Recognizing the benefits of TCM, exploring
potential interactions and adverse effects, and integrating
both healthcare approaches might be beneficial to the overall
health and quality of life of insomnia patients, particularly
those with a history of hypnotic dependence. Thus, health
care providers should proactively explore personalized, opti-
mal detoxification for hypnotic dependence while attending
to patients’ psychosocial and physical needs.
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